Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06064461 · ClinicalTrials.gov registry record
Vitaccess Real MG Registry
A clinical trial of Myasthenia Gravis, sponsored by Vitaccess.
- Recruiting
- Registry status
- 600
- Enrollment target
- 8
- Study locations
NCT06064461 is a study of Myasthenia Gravis that is actively recruiting participants, run by Vitaccess. The registered enrollment target is 600 participants, above the 172-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (249% higher). The trial reports 8 study locations across 8 states.
The verdict
NCT06064461, a study of Myasthenia Gravis, is actively recruiting participants, sponsored by Vitaccess.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 8
- Study locations
Study Summary
Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records. Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
Conditions Studied
Study Locations (8)
California
- UCI Health - Orange
Illinois
- HSHS St. Elizabeth's Hospital - O'Fallon
Kentucky
- UK HealthCare - University of Kentucky - Lexington
New Jersey
- Neurology Associates of South Jersey - Lumberton
South Carolina
- Medical University South Carolina - Charleston
Texas
- University of Texas Health Science Center at Houston - Houston
London
- Vitaccess Ltd - London
Other
- University Hospitals Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-07-31 |
| Est. Completion | 2034-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06064461
The ClinicalTrials.gov registry entry for NCT06064461 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 172-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (249% higher). The listed sponsor is Vitaccess, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 0 interventions.
NCT06064461 reports 8 study locations spanning 8 distinct geographic areas - top geographies include California, Illinois, Kentucky.
Frequently Asked Questions
What is clinical trial NCT06064461 about?
NCT06064461 is a clinical study titled "Vitaccess Real MG Registry". Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will ...
What is the current status of trial NCT06064461?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2024-07-31. Estimated completion is 2034-07.
What conditions does trial NCT06064461 study?
This clinical trial studies the following conditions: Myasthenia Gravis.
Who is sponsoring clinical trial NCT06064461?
This trial is sponsored by Vitaccess, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06064461 being conducted?
This trial has 8 study locations across California, Illinois, Kentucky, New Jersey, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.